Citations

Showing 10 of 108083 citations.

ACTA2 Expression Predicts Survival and Is Associated with Response to Immune Checkpoint Inhibitors in Gastric Cancer
Park, Sunho , Karalis, John D. , Hong, Changjin , Clemenceau, Jean R. , Kim, In‐Ho , Lee, Sung Hak , Wang, Sam C. , Cheong, Jae‐Ho , Hwang, Tae Hyun , Porembka, Matthew R , Kim, In-Ho , Lee, Sung Hak , Wang, Sam C , Cheong, Jae-Ho , Hwang, Tae Hyun

Mayo Clinic

Clinical Cancer Research | December 12, 2022 | Volume: 29 | Issue: 6 | Pages: 1077-1085

10.1158/1078-0432.ccr-22-1897 | PMID 36508166 Get It

Abstract Purpose: We sought to identify biomarkers that predict overall survival (OS) and response to immune checkpoint inhibitors (ICI) for patients with gastric cancer. Experimental Design: This was a retrospective study of multiple independent cohorts of patients with gastric cancer. The association between tumor ACTA2 expression and OS and ICI response were determined in patients whose tumors were analyzed with bulk mRNA sequencing. Single-cell RNA sequencing (scRNA-seq) and digital spatial profiling data were used to compare tumors from patients with gastric cancer who did and did not respond to ICI. Results: Increasing tumor ACTA2 expression was independently associated with worse OS in a 567-patient discovery cohort [HR, 1.28 per unit increase; 95% confidence interval (CI), 1.02–1.62]. This finding was validated in three independent cohorts (n = 974; HR, 1.52 per unit increase; 95% CI, 1.34–1.73). Of the 108 patients treated with ICI, 56% of patients with low ACTA2 expression responded to ICI versus 25% of patients with high ACTA2 expression (P = 0.004). In an analysis of a publicly available scRNA-seq dataset of 5 microsatellite instability-high patients treated with ICI, the patient who responded to ICI had lower tumor stromal ACTA2 expression than the 4 nonresponders. Digital spatial profiling of tumor samples from 4 ICI responders and 5 ICI nonresponders revealed that responders may have lower ACTA2 expression in α-SMA–positive cancer-associated fibroblasts (CAF) than nonresponders (median: 5.00 vs. 5.50). Conclusions: ACTA2 expression is associated with survival and ICI response in patients with gastric cancer. ACTA2 expression in CAFs, but not in other cellular compartments, appears to be associated with ICI response.
Selective vulnerability of brainstem and cervical spinal cord regions in people with non-progressive multiple sclerosis of Black or African American and European ancestry
Okuda, Darin T. , Stanley, Thomas , McCreary, Morgan , Smith, Alexander D. , Wilson, Andrew , Yu, Fang , Billiet, Thibo , Hecke, Wim Van , Ribbens, Annemie , Zeydan, Burcu , Kantarci, Orhun H. , Billiet, Thibo , Zeydan, Burcu , McCreary, M , Okuda, Darin T , Pinho, Marco C. , Guo, Xiaohu , Moog, Tatum M.

Mayo Clinic

Multiple Sclerosis Journal | December 12, 2022 | Volume: 29 | Issue: 6 | Pages: 691-701

10.1177/13524585221139575 | PMID 36507671 Get It

Background: We evaluated imaging features suggestive of neurodegeneration within the brainstem and upper cervical spinal cord (UCSC) in non-progressive multiple sclerosis (MS). Methods: Standardized 3-Tesla three-dimensional brain magnetic resonance imaging (MRI) studies were prospectively acquired. Rates of change in volume, surface texture, curvature were quantified at the pons and medulla-UCSC. Whole and regional brain volumes and T2-weighted lesion volumes were also quantified. Independent regression models were constructed to evaluate differences between those of Black or African ancestry (B/AA) and European ancestry (EA) with non-progressive MS. Results: 209 people with MS (pwMS) having at least two MRI studies, 29% possessing 3–6 timepoints, resulted in 487 scans for analysis. Median follow-up time between MRI timepoints was 1.33 (25th–75th percentile: 0.51–1.98) years. Of 183 non-progressive pwMS, 88 and 95 self-reported being B/AA and EA, respectively. Non-progressive pwMS demonstrated greater rates of decline in pontine volume ( p < 0.0001) in B/AA and in medulla-UCSC volume ( p < 0.0001) for EA pwMS. Longitudinal surface texture and curvature changes suggesting reduced tissue integrity were observed at the ventral medulla-UCSC ( p < 0.001), dorsal pons ( p < 0.0001) and dorsal medulla ( p < 0.0001) but not the ventral pons ( p = 0.92) between groups. Conclusions: Selectively vulnerable regions within the brainstem-UCSC may allow for more personalized approaches to disease surveillance and management.
Karius With a Q: Role for Microbial Cell-Free DNA Next-Generation Sequencing in Diagnosis of Acute Q Fever
Ranganath, Nischal , Saleh, Omar Abu , Abu Saleh, Omar M, Ranganath, Nischal , Khodadadi, Ryan B.

Mayo Clinic

Open Forum Infectious Diseases | December 12, 2022 | Volume: 10 | Issue: 1 | Pages: No page available

10.1093/ofid/ofac666 | PMID 36628055 Get It

Abstract The diagnosis of Q fever can be challenging and a high index of suspicion is necessary. Within this case series, we highlight the utility of the microbial cell-free DNA next-generation sequencing or Karius Test in the timely diagnosis and management of acute Q fever.
Shoulder Range of Motion Measurements and Baseball Elbow Injuries: Ambiguity in Scientific Models, Approach, and Execution is Hurting Overhead Athlete Health
Bullock, Garrett S. , Martin, Chelsea , Losciale, Justin M. , Tokish, John M. , Camp, Christopher L. , Shanley, Ellen , Camp, Christopher, Camp, Christopher L. , Thigpen, Charles A. , Michener, Lori Ann , Whiteley, Rod J. , Waterman, Brian Robert

Mayo Clinic

Arthroscopy, Sports Medicine, and Rehabilitation | December 12, 2022 | Volume: 5 | Issue: 1 | Pages: No page available

10.1016/j.asmr.2022.11.001 | PMID 36866292 Get It

Abstract Elbow injuries are a significant and increasing issue in baseball. Elbow injuries account for 16% of all injuries sustained at the professional level and collegiate level. Because of the continued rise in injury rates, loss of performance value, and medical burden, sports medicine clinicians have attempted to research the causes underlying this injury epidemic in an attempt to help mitigate baseball elbow injuries. Shoulder range of motion (ROM) is the most researched clinical metric related to elbow injuries in baseball and has the greatest consensus as a viable prognostic factor specifically for medial elbow injury. Shoulder ROM is easy to measure, can be modified through stretching and manual therapy interventions, and can be easily assessed during preseason screening throughout all baseball levels. Despite a large number of studies and the widespread use of shoulder ROM in injury risk screening, current findings are unclear as to whether there is a true cause‐effect relation with baseball elbow injuries. We argue that the conflicting findings revolving around the value of shoulder ROM measurements associated with baseball elbow injuries are the result of 4 gaps in the research approaches implemented to date: ambiguous research questions, mixed study populations, statistical models used, and shoulder ROM methodology. Specifically, there is a mismatch of methods, statistical models, and conclusions such as (1) investigating the association (i.e., correlation) between shoulder ROM measurements and injury and (2) investigating the cause‐effect relation of shoulder ROM to baseball injuries. The purpose of this article is to detail the required scientific steps to evaluate whether preseason shoulder ROM is a potential causal factor for pitching elbow injury. We also provide recommendations to allow for future causal inferences to be made between shoulder ROM and elbow injury. This information will ultimately assist in informing clinical models of care and decision making for baseball throwers.
Time to second treatment can be used to predict overall survival in chronic lymphocytic leukemia: identifying risk factors to help guide treatment selection
Bantilan, Kurt S. , Parikh, Sameer A. , Rabe, Kari G. , Call, Timothy G. , Leis, José F., Soumerai, Jacob D. , Mato, Anthony R. , Parikh, Sameer A , Soumerai, Jacob D , Zelenetz, Andrew D , Chaffee, Kari G. , Kay, Neil E. , Ding, Wei , Slager, Susan L. , Roeker, Lindsey E. , Zelenetz, Andrew D.

Mayo Clinic

Leukemia & Lymphoma | December 12, 2022 | Volume: 64 | Issue: 2 | Pages: 300-311

10.1080/10428194.2022.2148218 | PMID 36503412 Get It

Antibody responses to the host microbiome in chronic rhinosinusitis
Lal, Devyani , Song, Lusheng , Cope, Emily K. , Williams, Stacy , Magee, D. Mitchell, Brar, Tripti , Lal, Devyani , Keim, Paul , Chung, Yunro , Murugan, Vel , LaBaer, Joshua

Mayo Clinic

International Forum of Allergy & Rhinology | December 12, 2022 | Volume: 13 | Issue: 8 | Pages: 1503-1510

10.1002/alr.23107 | PMID 36504343 Get It

AbstractBackgroundThe role of microbes in chronic rhinosinusitis (CRS) is poorly understood. We hypothesize that analyzing prior microbial exposures via assessing microbial protein serological reactivity in CRS versus controls may offer insights for CRS etiopathogenesis.MethodsWe profiled IgG and IgA antibodies to individual microbial proteins in serum samples of CRS patients and controls using a novel high‐throughput microarray protein technology, Nucleic Acid Programmable Protein Array (NAPPA). The study was conducted on 118 subjects (39 CRS, 79 controls). A CRS‐focused NAPPA array, with 1557 potentially sero‐reactive microbial proteins elected from a pre‐screening of 6500 genes of interest was constructed. It included membrane‐associated proteins from 47 bacterial species and all proteins from 43 viral strains. Differences between CRS and controls were compared across individual antimicrobial antibodies and the species.ResultsChronic rhinosinusitis patients had significantly elevated antimicrobial antibodies compared with controls. One bacterium (Staphylococcus aureus) and three viral strains (human metapneumovirus, human herpesvirus 5, and human herpesvirus 4) were identified as sources of the proteins that showed significantly elevated sero‐reactivity in CRS patients. Within CRS, patients with polyps had elevated antibodies against S. aureus, influenza A virus (H1N1, H3N2), and rhinovirus B14. CRS patients without polyps showed more antibodies against human herpesvirus 1 and vaccinia virus WR.ConclusionsCompared with healthy controls, CRS patients’ serum samples showed significantly increased sero‐reactivity to both bacterial and viral proteins, reflecting recent or current infection or active colonization. Significantly higher antibodies against S. aureus, human metapneumovirus, human herpesvirus 5, and human herpesvirus 4 in CRS need further study.
Abdominal and robotic sacrocolpopexy costs following implementation of enhanced recovery after surgery
Baker, Mary V. , Trad, Ayssa Teles Abrão , Tamhane, Prajakta, Weaver, Amy L. , Visscher, Sue L. , Klingele, Christopher J., Gebhart, John B. , Trabuco, Emanuel C. , Teles Abrao Trad, Ayssa, Borah, Bijan J.

Mayo Clinic

International Journal of Gynecology & Obstetrics | December 12, 2022 | Volume: 161 | Issue: 2 | Pages: 655-660

10.1002/ijgo.14623 | PMID 36504261 Get It

AbstractObjectiveTo compare perioperative costs and morbidity between open and robotic sacrocolpopexy after implementation of enhanced recovery after surgery (ERAS) pathway.MethodsThe present retrospective cohort study of patients undergoing open or robotic sacrocolpopexy (January 1, 2014, through November 30, 2017) used an ERAS protocol with liposomal bupivacaine infiltration of laparotomy incisions. Primary outcomes were costs associated with index surgery and hospitalization, determined with Medicare cost‐to‐charge ratios and reimbursement rates and adjusted for variables expected to impact costs. Secondary outcomes included narcotic use, length of stay (LOS), and complications from index hospitalization to postoperative day 30.ResultsFor the total of 231 patients (open cohort, 90; robotic cohort, 141), the adjusted mean cost of robotic surgery was $3239 higher compared with open sacrocolpopexy (95% confidence interval [CI] $1331–$5147; P < 0.001). Rates were not significantly different for intraoperative complications (robotic, 4.3% [6/141]; open, 5.6% [5/90]; P = 0.754), 30‐day postoperative complications (robotic, 11.4% [16/141]; open, 16.7% [15/90]; P = 0.322), or readmissions (robotic, 5.7% [8/141]; open, 3.3% [3/90]; P = 0.535). The percentage of patients dismissed on postoperative day 1 was greater in the robotic group (89.4% [126/141] vs. 48.9% [44/90], P < 0.001).ConclusionsDecreased LOS associated with ERAS provided significant cost savings with open sacrocolpopexy versus robotic sacrocolpopexy without adverse impacts on perioperative complications or readmissions.
T Cell Transcriptional Signatures of Influenza A/H3N2 Antibody Response to High Dose Influenza and Adjuvanted Influenza Vaccine in Older Adults
Haralambieva, Iana H. , Ovsyannikova, Inna G. , Goergen, Krista M., Grill, Diane E. , Kennedy, Richard B. , Quach, Huy Quang , Kennedy, Richard , Poland, Gregory A.

Mayo Clinic

Viruses | December 12, 2022 | Volume: 14 | Issue: 12 | Pages: 2763

10.3390/v14122763 | PMID 36560767 Get It

Older adults experience declining influenza vaccine-induced immunity and are at higher risk of influenza and its complications. For this reason, high dose (e.g., Fluzone) and adjuvanted (e.g., Fluad) vaccines are preferentially recommended for people age 65 years and older. However, T cell transcriptional activity shaping the humoral immune responses to Fluzone and Fluad vaccines in older adults is still poorly understood. We designed a study of 234 older adults (≥65 years old) who were randomly allocated to receive Fluzone or Fluad vaccine and provided blood samples at baseline and at Day 28 after immunization. We measured the humoral immune responses (hemagglutination inhibition/HAI antibody titer) to influenza A/H3N2 and performed mRNA-Seq transcriptional profiling in purified CD4+ T cells, in order to identify T cell signatures that might explain differences in humoral immune response by vaccine type. Given the large differences in formulation (higher antigen dose vs adjuvant), our hypothesis was that each vaccine elicited a distinct transcriptomic response after vaccination. Thus, the main focus of our study was to identify the differential gene expression influencing the antibody titer in the two vaccine groups. Our analyses identified three differentially expressed, functionally linked genes/proteins in CD4+ T cells: the calcium/calmodulin dependent serine/threonine kinase IV (CaMKIV); its regulator the TMEM38B/transmembrane protein 38B, involved in maintenance of intracellular Ca2+ release; and the transcriptional coactivator CBP/CREB binding protein, as regulators of transcriptional activity/function in CD4+ T cells that impact differences in immune response by vaccine type. Significantly enriched T cell-specific pathways/biological processes were also identified that point to the importance of genes/proteins involved in Th1/Th2 cell differentiation, IL-17 signaling, calcium signaling, Notch signaling, MAPK signaling, and regulation of TRP cation Ca2+ channels in humoral immunity after influenza vaccination. In summary, we identified the genes/proteins and pathways essential for cell activation and function in CD4+ T cells that are associated with differences in influenza vaccine-induced humoral immunity by vaccine type. These findings provide an additional mechanistic perspective for achieving protective immunity in older adults.
Areas of Uncertainty in SARS-CoV-2 Vaccination for Cancer Patients
Dimou, Anastasios , Dimou, Anastasios

Mayo Clinic

Vaccines | December 12, 2022 | Volume: 10 | Issue: 12 | Pages: 2117

10.3390/vaccines10122117 | PMID 36560527 Get It

Early in the COVID-19 pandemic, it was recognized that infection with SARS-CoV-2 is associated with increased morbidity and mortality in patients with cancer; therefore, preventive vaccination in cancer survivors is expected to be particularly impactful. Heterogeneity in how a neoplastic disease diagnosis and treatment interferes with humoral and cellular immunity, however, poses a number of challenges in vaccination strategies. Herein, the available literature on the effectiveness of COVID-19 vaccines among patients with cancer is critically appraised under the lens of anti-neoplastic treatment optimization. The objective of this review is to highlight areas of uncertainty, where more research could inform future SARS-CoV-2 immunization programs and maximize benefits in the high-risk cancer survivor population, and also minimize cancer treatment deviations from standard practices.
Isolated Jaw and Tongue Tremor in a Definite Case of Progressive Supranuclear Palsy
Olfati, Nahid , Haubenberger, Dietrich , Dickson, Dennis W. , Shoeibi, Ali , Litvan, Irene

Mayo Clinic

Movement Disorders Clinical Practice | December 12, 2022 | Volume: 10 | Issue: 2 | Pages: 348-349

10.1002/mdc3.13640 | PMID 36825063 Get It